Full Text View
Tabular View
No Study Results Posted
Related Studies
Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
This study has been completed.
Study NCT00528385   Information provided by Medical University of Gdansk
First Received: September 11, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Disease
Proteinuria
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Failure
Renal Insufficiency
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Spironolactone (Spironol) 25 mg
Additional drug interventions recognized in this trial
Aldosterone Antagonists
Spironolactone
More general drug interventions related to this trial
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Medical University of Gdansk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services